United States · Platforms & data · MarketBeat

Milestone Pharmaceuticals (NASDAQ:MIST) Stock Rating Upgraded by Wall Street Zen

Published by MarketBeat · United States 14 min ago

Image from MarketBeat Media, LLC. · MarketBeat

Detailed summary

Wall Street Zen raised shares of Milestone Pharmaceuticals from a "strong sell" rating to a "sell" rating in a report on Saturday.

Read the full article on MarketBeat Sign in to save

MarketNews shows the headline and summary published by the outlet. The full article is on the publisher's website. (www.marketbeat.com)

Also worth reading

The Motley Fool

Prediction: 2 Stocks That Will Be Worth More Than SpaceX 5 Years From Now

ArrowMark Financial declares $0.15 dividend

FAA lifts rare nationwide ground stop on flights; air travel may take days to recover

Trump Reportedly Plans To Not Raise Nvidia Spy Issue During China Trip — Elon Musk To Accompany US President

Planning to Claim Social Security at 62? Here Are 3 Critical Questions to Ask Yourself First

Lutnick faces questions over Nvidia spy scandal. His sons' firm has deep ties to the chipmaker